Specifically, the U.S. administration cited a research printed final summer time which discovered a hyperlink between paracetamol throughout being pregnant and elevated incidence of neuro-developmental issues (NDDs). However on this evaluate “there are a number of research [which] undergo or are susceptible to bias,” Khalil mentioned. “The potential implications of not accounting for these confounders is that you simply draw their very own conclusions.”
The Lancet’s proof evaluate as a substitute centered on research with essentially the most rigorous analysis strategies, akin to these at low danger of bias, these with sibling comparisons and with at the very least 5 years of comply with up — and located no hyperlink.
Specifically, sibling-comparison research permit researchers to match youngsters born to the identical mom, who solely took paracetamol throughout one of many pregnancies. They bear in mind shared genetic elements, shared household and long-term parental traits.
“Our findings recommend that beforehand reported hyperlinks are prone to be defined by genetic predisposition or different maternal elements akin to fever or underlying ache, fairly than a direct impact of the paracetamol itself,” Khalil mentioned.
Public well being consultants, the EMA and the European Fee, pushed again in opposition to Trump’s place final 12 months, arguing there was no proof to assist it.
“Whereas the influence of final 12 months’s announcement has been intensive, I hope the findings of this research convey the matter to a detailed,” Grainne McAlonan, professor of translational neuroscience at King’s School London, mentioned.
“Expectant moms don’t want the stress of questioning whether or not medication mostly used for a headache may have far reaching results on their little one’s well being,” McAlonan mentioned.
